Nucleophosmin (NPM/B23) is a multifunctional oncoprotein whose protein expression levels dictate cellular growth and proliferation rates. NPM is translationally responsive to hyperactive mammalian target of rapamycin (mTOR) signals, but the mechanism of this regulation is not understood. Using chimeric translational reporters, we found that the 3 0 untranslated region (UTR) of the NPM messenger (m)RNA is sufficient to mediate its translational modulation by mTOR signalling. We show that far upstream element (FUSE)-binding protein 1 (FBP1) interacts specifically with the 3 0 UTR of NPM to repress translation. Overexpression of FBP1 resulted in translational repression of NPM mRNAs, whereas depletion of FBP1 caused a dramatic increase in NPM translation and resulted in enhanced overall cell proliferation. Thus, we propose that FBP1 is a key regulator of cell growth and proliferation through its ability to selectively bind the NPM 3 0 UTR and repress NPM translation.
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Introduction
Translational regulation functions as a critical mode by which cells direct protein expression. Translational control of select messenger (m)RNAs is often mediated by regulatory proteins that interact with sequence elements within the 5 0 and/or 3 0 untranslated regions (UTRs) of transcripts (Gebauer and Hentze, 2004) . Compared with regulatory protein-RNA interactions in the 3 0 UTR, however, those in the 5 0 UTR are relatively rare (Jackson et al., 2010) . Consistent with this notion, numerous studies have demonstrated important regulatory protein-mRNA interactions in the 3 0 UTRs of various transcripts (Irwin et al., 1997; Brennan and Steitz, 2001; Wickens et al., 2002; Zhang et al., 2002; Mazan-Mamczarz et al., 2003; de Moor et al., 2005; Galban et al., 2008; Hamilton et al., 2008) . Thus, it is clear that UTRs, and particularly the 3 0 UTR, are essential regulators of the protein expression machinery.
Nucleophosmin (NPM/B23) is a nucleolar oncoprotein involved in a myriad of central cellular processes, including ribosome biogenesis (Okuwaki et al., 2002) , protein chaperoning (Okuwaki et al., 2001) , centrosome duplication (Okuda et al., 2000) , transcriptional regulation (Colombo et al., 2002) and cellular growth and proliferation (Brady et al., 2004; Grisendi et al., 2005 Grisendi et al., , 2006 . NPM has a crucial role in modulating the rate of 40S and 60S ribosomal subunit export from the nucleolus/nucleus to the cytoplasm, thereby functioning as a chaperone for the ribosome Maggi et al., 2008) . Through this mechanism, NPM is able to enhance protein synthesis and promote cellular growth (Maggi et al., 2008) . NPM is overexpressed in several neoplasms, such as ovarian, colon, prostate, bladder and gastric cancers (Sandsmark et al., 2007; Qi et al., 2008) . As a potent oncoprotein, it is important to understand the regulation of NPM expression.
Previous data demonstrated that NPM protein expression is induced by hyperactive mammalian target of rapamycin (mTOR) signalling caused by either overexpression of constitutively active H-Ras or loss of Tsc1 . Induction of NPM protein expression is clearly mTOR-dependent, as NPM induction was abrogated upon treatment with rapamycin, a selective inhibitor of mTOR (Wullschleger et al., 2006) , or overexpression of TSC1 . Interestingly, NPM mRNA expression is insensitive to rapamycin, suggesting that NPM is regulated primarily at the level of translation.
Here, we establish that NPM expression is controlled translationally and that the NPM 3 0 UTR alone is sufficient to impart endogenous NPM-like translational modulation onto a luciferase reporter open reading frame (ORF). Additionally, we identified far upstream element (FUSE)-binding protein 1 (FBP1) as a novel NPM 3 0 UTR mRNA-binding protein that represses translation of the NPM transcript. Through modulation of NPM, FBP1 has an important role in the regulation of cell growth and proliferation.
Results
Inhibition of mTOR induces NPM mRNA exclusion from actively translating ribosomes Signals emanating from hyperactivated mTOR signalling stimulate the translation of NPM, resulting in increased NPM protein expression in the absence of significant changes in NPM mRNA levels . To further examine the apparent translational control of NPM, Tsc1
À/À mouse embryonic fibroblasts (MEFs), which display activated mTOR (Tee et al., 2002) , were treated with rapamycin. NPM protein induction was attenuated upon rapamycin treatment (Figure 1a) , even in the presence of slightly elevated levels of NPM transcripts (Supplementary Figure 1a) , indicating that the rapamycin-induced reduction in NPM protein expression is not due to reduced cellular NPM mRNAs.
We hypothesized that rapamycin treatment might result in the exclusion of NPM mRNAs from actively translating polyribosomes or polysomes. To test this, cytosolic ribosomes were isolated by sucrose gradient centrifugation from equal numbers of Tsc1
MEFs treated with vehicle or rapamycin. Ribosomal subunits were detected by continuous measurement of RNA absorbance (A 254nm ). Treatment with rapamycin dramatically reduced the overall formation of polysomes actively engaged in mRNA translation (Figure 1b) . To evaluate the distribution of NPM transcripts in monosomes/disomes and polysomes, NPM mRNA levels in sucrose gradient fractions were measured by quantitative real-time PCR. Strikingly, despite a modest increase in the total cellular pool of NPM mRNAs in rapamycin-treated cells compared with vehicle-treated cells (Supplementary Figure 1a) , the percentage of NPM transcripts associated with actively translating polysomes was dramatically diminished upon rapamycin treatment (Figure 1c ). Accumulation of NPM mRNAs was apparent in monosomes/disomes, particularly 80S fractions, in cells treated with rapamycin ( Figure 1c ), which is consistent with previous studies (Jefferies et al., 1997) . To test that our findings for NPM were specific for an mRNA that is translationally responsive to mTOR signals, we treated cells with rapamycin and analyzed GAPDH mRNAs. Rapamycin had no effect on the distribution of GAPDH mRNAs in monosome/disome or polysome fractions (Figure 1d ), consistent with previous findings (Terada et al., 1994) . Importantly, unchanged GAPDH transcript distribution upon rapamycin treatment suggests that inhibition of mTOR did not globally affect all cellular mRNA translation, which is in accordance with previous reports (Mendez et al., 1996) . Taken together, these data indicate that NPM expression is responsive to hyperactive mTOR signalling at the level of translation.
The NPM 3
0 UTR is sufficient to confer NPM-like translational regulation properties to a luciferase ORF Recognition and binding of elements within the 5 0 and 3
0
UTRs of mRNAs by regulatory proteins is a common mechanism underlying selective mRNA translational control (Gebauer and Hentze 2004) . Indeed, previous reports have indicated that various mRNAs are subject to such regulation (Irwin et al., 1997; Pontrelli et al., 2004; Takagi et al., 2005; Jiang et al., 2006; Sidiropoulos et al., 2007; Zhang et al., 2008) . To determine whether a comparable mechanism may be responsible for the translational regulation of NPM, we first identified the 5 0 UTR sequence of the NPM transcript by rapid amplification of complementary DNA ends (RACE) (Supplementary Figure 2a ; GenBank accession number GU214027). Like the human NPM 5 0 UTR (Meyuhas 2000) , RACE revealed that the murine NPM 5 0 UTR contains a canonical terminal oligopyrimidine tract also contained in the 5 0 UTRs of transcripts encoding ribosomal proteins, elongation factors and other components of the translational machinery (Proud 2007 (Proud , 2009 ). For use as a control, we utilized RACE to FBP1 regulates NPM translation ME Olanich et al determine the sequence of the GAPDH 5 0 UTR (GenBank accession number GU214026). We attained the complete NPM and GAPDH 3 0 UTR sequences from GenBank (accession numbers BC054755.1 and NM_008084.2, respectively) (Supplementary Figure 2a) .
To investigate whether the NPM 5 0 and 3 0 UTRs may be important for regulation of the NPM mRNA, we sought to evaluate whether the NPM 5 0 and 3 0 UTRs were sufficient to modulate translation of another ORF in a manner equivalent to translational regulation of the NPM ORF. Specifically, we wanted to determine whether fusion of the NPM 5 0 and 3 0 UTRs to a firefly luciferase (Fluc) ORF rendered Fluc expression sensitive to rapamycin. To test this, Tsc1 To examine the independent roles of each NPM UTR as potential targets of regulation, we generated chimeric reporters by fusing the NPM 5 0 UTR and the GAPDH 3 0 UTR or the GAPDH 5 0 UTR and the NPM 3 0 UTR to the respective ends of the Fluc ORF (Supplementary Figure 2b) . Surprisingly, NPM 5 0 -luc-GAPDH 3 0 activity resembled GAPDH 5 0 -luc-GAPDH 3 0 activity, with rapamycin having no effect at any time point measured ( Figure 2c ). GAPDH 5 0 -luc-NPM 3 0 activity, however, demonstrated rapamycin sensitivity similar to that observed with NPM 5 0 -luc-NPM 3 0 activity ( Figure 2d ). Collectively, these data suggest that sequences within the NPM 3 0 UTR, but not in the NPM 5 FBP1 regulates NPM translation ME Olanich et al translation, as the NPM 3 0 UTR alone was sufficient to render the Fluc ORF rapamycin-sensitive. Given that rapamycin sensitivity of 5 0 terminal oligopyrimidine tract mRNAs ranges from resistance to marked repression (Patursky-Polischuk et al., 2009) , these data are in accordance with the poorly understood role of the 5 0 terminal oligopyrimidine tract. Our findings are consistent with reports highlighting the paucity of regulatory protein-RNA interactions in the 5 0 UTR, but the abundance of examples for 3 0 UTR-protein regulation (Jackson et al., 2010) .
FBP1 interacts specifically with the NPM 3
0 UTR Although reporter assay data (Figures 2a-d) indicated that only the NPM 3 0 UTR is important for modulation of the NPM mRNA, we undertook an unbiased approach to screen for putative regulatory binding proteins of the NPM 5 0 and 3 0 UTRs. We utilized an RNA pull-down assay coupled to mass spectrometry to identify proteins that bind the NPM 5 0 or 3 0 UTR. Whole cell lysates prepared from Tsc1
À/À MEFs treated with vehicle or rapamycin were incubated with biotinylated NPM 5 0 UTR or 3 0 UTR RNA. Several proteins were found to preferentially interact with the NPM 3 0 UTR, but none appeared to bind exclusively to the NPM 5 0 UTR, consistent with reporter assay findings (Figure 3a , arrows). We next employed mass spectrometry to identify putative NPM 3 0 UTR binding proteins and confirmed their identities as FBP1, FBP2 (also known as KHSRP or KSRP) and heterogeneous nuclear ribonucleoprotein A/B (Figure 3a ; Supplementary Figure 3 ). It should be noted that mass spectrometry also identified non-FBP1 and 2 peptides from the stained bands depicted, suggesting that proteins other than FBP1 and 2 co-exist at this molecular weight on the gel. As the A/B subfamily of heterogeneous nuclear ribonucleoproteins refer to several promiscuous, multifunctional RNA binding proteins (He and Smith, 2009) , subsequent experiments focused on evaluating the roles of FBPs in NPM translational regulation.
The FBP family is most noted for its transcriptional activation of c-myc (Duncan et al., 1994; He et al., 2000) ; however, the FBPs have also been reported to bind several RNAs, though in vitro studies only (Chung et al., 2006 
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À/À MEFs treated with vehicle or rapamycin. FBP1 and FBP2 were visualized by western blot analysis of UTR-precipitated samples (Figure 3b ). Although FBP3 was not identified by mass spectrometry (Figure 3a; Supplementary Figure 3) , we also analyzed it by immunoblot assay, as it is a member of the highly related FBP protein family. Consistent with analyses from mass spectrometry, however, FBP3 was undetectable. FBP1 was precipitated exclusively by the NPM 3 0 UTR (Figure 3b ). FBP2 was precipitated predominantly by the NPM 3 0 UTR, but also by the GAPDH 3 0 UTR and the NPM 5 0 UTR in vehicletreated cells (Figure 3b) . The more promiscuous RNA FBP1 regulates NPM translation ME Olanich et al binding by FBP2 is in agreement with previous reports implicating FBP2 in RNA editing, RNA trafficking, RNA stabilization and RNA decay (Min et al., 1997; Kroll et al., 2002; Snee et al., 2002; Briata et al., 2003 Briata et al., , 2005 Gherzi et al., 2004; Li et al., 2009) . However, given that the interaction of FBP1 with the NPM 3 0 UTR appeared to be specific, especially in the presence of rapamycin, we focused on the role of FBP1 in modulating NPM translation.
We next sought to verify the interaction of FBP1 with endogenous NPM mRNAs. FBP1 was immunoprecipitated from whole cell extracts prepared from Tsc1
À/À MEFs treated with vehicle or rapamycin (Figure 3c, top) . Total RNA was isolated from FBP1 immunoprecipitates, and bound NPM mRNA was measured by quantitative real-time PCR. Significantly higher numbers of NPM transcripts were associated with FBP1 in rapamycin-treated cells versus vehicletreated cells (Figure 3c, bottom) . Interestingly, FBP1 protein expression dramatically increased upon inhibition of mTOR (Supplementary Figure 4) , suggesting that the enhanced affinity of FBP1 for the NPM 3 0 UTR in the presence of rapamycin was a result of induced FBP1 expression. Additionally, we did not observe any post-translational modification in identified FBP1 peptides by mass spectrometry ( Supplementary  Figure 3) , again suggesting that a change in FBP1 expression may be sufficient to drive its interaction with the NPM 3 0 UTR.
FBP1 overexpression represses NPM translation
To explore the functional role of FBP1 in NPM translational regulation, we evaluated the effects of FBP1 overexpression. Ectopic expression of Flag epitope-FBP1 in Tsc1
MEFs drastically reduced NPM protein levels (Figure 4a ). Consistent with FBP1 functioning as a translational regulator of NPM expression, NPM mRNA levels remained unchanged upon FBP1 overexpression (Supplementary Figure 1b) . We questioned whether FBP1 overexpression could mimic inhibition of mTOR by reducing polysome-associated NPM transcripts. To test this, cytosolic ribosomes were isolated by sucrose gradient centrifugation from equal numbers of Tsc1
MEFs transduced with vector or Flag-tagged FBP1. Unlike rapamycin treatment, FBP1 overexpression failed to dramatically diminish the overall formation of polysomes (Figure 4b) . Distribution of NPM transcripts in monosome/disome and polysome fractions, however, was analogous to the NPM mRNA distribution observed upon inhibition of mTOR (Figure 4c and Figure 1c) . In cells overexpressing FBP1, exclusion of NPM mRNAs from polysomes and accumulation in 80S fractions was visible although less pronounced compared with the shift of NPM transcripts from polysomes to monosomes/disomes measured in rapamycin-treated cells (Figure 4c and Figure 1c) .
Mechanistically, we questioned whether FBP1 overexpression induces the formation of processing bodies or stress granules. To test this, we transduced Tsc1 
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As demonstrated by immunofluorescent detection of TIA-1, a marker of stress granules (Yang et al., 2006) , arsenite treatment but not ectopic expression of Flag-FBP1 induced stress granule accumulation (Supplementary Figure 5 ). Thus, FBP1 overexpression is not sufficiently stressful to stimulate aggregation of stalled translation pre-initiation complexes (Kedersha et al., 2005) . Nonetheless, these findings demonstrate that FBP1 represses NPM translation.
Depletion of FBP1 enhances NPM translation and cell proliferation
To further investigate the functional role of FBP1 as a translational regulator of NPM expression, we transduced Tsc1 À/À p53 À/À MEFs with control small interfering (si)RNA or two different siRNAs targeting murine FBP1. The presence of FBP1-siRNA #2 caused a marked reduction in FBP1 protein, whereas FBP1-siRNA #3 yielded a more modest decrease (Figure 5a ). Increase in NPM protein expression correlated with the amount of FBP1 reduction, as siRNA #2 resulted in higher NPM induction than that observed with siRNA #3 (Figure 5a ). Again, consistent with NPM protein expression being regulated independent of transcription, NPM mRNA levels remained constant in the presence of either siRNA targeting FBP1 (Supplementary Figure 1c) .
We next wanted to determine whether depletion of FBP1 leads to enhanced polysome-associated NPM transcripts. We isolated cytosolic ribosomes by sucrose gradient centrifugation from equal numbers of Tsc1
À/À MEFs transduced with control siRNA or two siRNAs targeting FBP1. Depletion of FBP1 resulted in elevated formation of polysomes actively engaged in mRNA translation ( Figure 5b ). As observed with NPM protein induction (Figure 5a ), polysome enhancement corresponded with the degree of FBP1 reduction (Figure 5b ). Furthermore, also relative to the amount of FBP1 depletion, NPM transcripts associated with actively translating polysomes were dramatically elevated in the presence of siRNAs targeting FBP1 compared with control siRNA (Figure 5c ).
Based on the striking enhancement of ribosome recruitment to NPM mRNAs observed upon FBP1 depletion and previous reports demonstrating the ability of NPM to potently promote proliferation (Maggi et al., 2008; Brady et al., 2009) , we sought to explore the effects of FBP1-mediated NPM induction on cellular proliferation. In cells depleted of FBP1, we observed increased proliferation rates relative to control siRNA-transfected cells (Figure 5d ). Again, enhancement of proliferation correlated with the amount of FBP1 reduction. Importantly, enhanced proliferation was abrogated in cells depleted of FBP1 and NPM (Figure 5e ), indicating that elevated NPM protein expression indeed underlies the increased proliferation rates observed upon FBP1 depletion. Taken together, these findings indicate that FBP1 is necessary to restrain NPM translation and, thereby, cell proliferation.
Discussion
Here, we have demonstrated that NPM expression is regulated at the level of translation and that the 3 0 UTR of the NPM mRNA is sufficient to confer rapamycin sensitivity to a reporter ORF. Further analyses identified FBP1 as a protein that selectively interacts with the NPM 3 0 UTR. FBP1 overexpression and knockdown data are consistent with FBP1 functioning to negatively regulate translation of NPM mRNAs.
Though we have demonstrated that NPM mRNAs are largely excluded from polysomes by FBP1, further FBP1 regulates NPM translation ME Olanich et al studies will be needed to provide insight into the precise mechanism by which FBP1 binding to the NPM 3 0 UTR negatively regulates NPM translation. It appears that FBP1 represses NPM translation by interfering with translation initiation, as the shift in NPM mRNA distribution from polysomes to monosomes/disomes is indicative of a reduced translation initiation rate (Meyuhas, 2000) .
Collectively, our data suggest that FBP1 acts as a suppressor of proliferation through its direct repression of NPM translation. This is consistent with the requirement of NPM expression for continued cellular proliferation and growth both in vitro and in vivo (Grisendi et al., 2005; Maggi et al., 2008; Brady et al., 2009) . By targeting NPM, FBP1 appears to at least mimic the functional activity of the ARF tumor suppressor. Numerous studies have shown that ARF binds directly to NPM to inhibit its activity and prevent cell growth (Itahana et al., 2003; Bertwistle et al., 2004; Brady et al., 2004) . Through its ability to repress NPM translation, FBP1 also antagonizes NPM to suppress cell growth and proliferation. Of particular interest is the question of whether FBP1, like ARF, utilizes its anti-NPM function to serve as a tumor suppressor.
Materials and methods

Cell culture and transfection Tsc1
À/À p53 À/À MEFs were maintained in DMEM supplemented as described previously . For bioluminescence assays, transfections were performed using Lipofectamine 2000 transfection reagent (Invitrogen, Carlsbad, CA, USA). All other transfections were carried out using the Nucleofector system (Amaxa, Walkersville, MD, USA) according to the manufacturer's instructions. 
Western blot analyses Tsc1
À/À p53 À/À MEFs were lysed by sonication in EBC buffer as previously described (Maggi et al., 2008) . The following antibodies were used at the dilutions indicated: anti-NPM (Santa Cruz, Santa Cruz, CA, USA, sc6013; 1:1000), anti-gtubulin (Santa Cruz, sc17787; 1:500), anti-FBP1 (Abcam, Cambridge, MA, USA, ab28732; 1:1600; western blot only), anti-FBP1 (Santa Cruz, sc11101; 1:500; immunoprecipitation only), anti-FBP2 (Abnova, Taipei City, Taiwan, H00008570-A01; 1:2000), anti-FBP3 (Santa Cruz, sc11103; 1:500), and anti-Flag M2 (Sigma, St Louis, MO, USA, F1804; 1:1000). ImageScanner III (GE Healthcare, Piscataway, NJ, USA) was used to scan autoradiograms, and densities were measured with ImageQuant V. 2005 (GE Healthcare).
Immunoprecipitations Tsc1
À/À MEFs were treated with vehicle or rapamycin for 48 h and lysed by sonication in EBC buffer as described above. Whole cell lysates (500 mg) were pre-cleared with 50 ml of protein A/G PLUS-agarose (Santa Cruz, sc2003) for 1 h at 4 1C with rotation. Pre-cleared lysates were then subjected to immunoprecipitation using anti-FBP1 antibody (Santa Cruz, sc11101) or non-immune goat serum (Santa Cruz, 2028).
Quantitative RT-PCR Total RNA was extracted from Tsc1
À/À MEFs with RNA-Solv (Omega Bio-tek, Norcross, GA, USA). Reverse transcription reactions were performed using the SuperScript III first-strand synthesis system (Invitrogen) with oligo d(T) primer according to the manufacturer's instructions. Real-time PCR was performed on an iCycler apparatus (Bio-Rad, Hercules, CA, USA). To amplify NPM and GAPDH mRNAs from monosome/disome and polysome fractions, we used SsoFast EvaGreen supermix (Bio-Rad) and the following primers: NPM: forward, 5 0 -GGAAGACTCGATGGATA TGG-3 0 ; reverse, 5 0 -CTTCAACCGTAAGACCACAGG-3 0 ; GAPDH: forward, 5 0 -GCTGGGGCTCACCTGAAGGG-3 0 ; reverse, 5 0 -GGATGACCTTGCCCACAGCC-3 0 . To measure NPM mRNA in immunoprecipitates, the primers used are described above. Numbers of NPM transcripts per cell were calculated by extrapolation from a standard curve generated from serial dilutions of a known quantity of subcloned NPM complementary DNA. To amplify NPM mRNA or firefly luciferase mRNA not isolated from ribosome fractions or immunoprecipitates, iQ Sybr green supermix (Bio-Rad) was used. Histone 3.3 mRNA was amplified as an expression control. For NPM, the primers used are described above. (Gross and Piwnica-Worms, 2005) .
Ribosome fractionation
Cells were treated with cycloheximide (10 mg/ml) before harvesting and counting. Equal numbers of cells (3 Â 10 6 ) were lysed, and cytosolic extracts were subjected to ribosome fractionation as previously described (Strezoska et al., 2000) using a density gradient system (Teledyne ISCO, Lincoln, NE, USA).
In vitro transcription DNA templates for in vitro transcription were GAPDH 5 0 UTR, GAPDH 3 0 UTR, NPM 5 0 UTR and NPM 3 0 UTR PCR products cloned into the pCR 2.1-TOPO vector (Invitrogen). To increase proximity of the UTR sequence to the T7 promoter, we excised the EcoRV-ApaI fragment between the PCR product and T7 promoter. DNA was linearized by digestion with BstXI. We used the Megashortscript kit (Ambion, Austin, TX, USA) for transcription with 0.5 mM biotinylated UTP (Enzo Life Sciences, Plymouth Meeting, PA, USA) and 7.5 mM ATP, CTP, GTP and UTP.
RNA pull-down assay For analysis by mass spectrometry, whole cell lysates (500 mg) prepared from Tsc1 À/À p53 À/À MEFs treated with vehicle or rapamycin were pre-cleared with 50 ml streptavidin sepharose (GE Healthcare). Pre-cleared lysates were then incubated with biotinylated GAPDH 5 0 or 3 0 UTR RNA or NPM 5 0 or 3 0 UTR RNA (20 mg) in binding buffer (10 mM HEPES (pH 7.5), 90 mM potassium acetate, 1.5 mM magnesium acetate, 40 mM KCl, 2.5 mM DTT, 0.05% NP40, protease inhibitor cocktail and 0.5 mM PMSF). Protein and biotinylated RNA mixtures were recovered by incubation with 50 ml streptavidin sepharose. Eluted proteins were separated on 10% polyacrylamide SDS gels and stained with SYPRO-Ruby dye. To validate results from mass spectrometry, RNA pull-down assays were performed as described, but amounts of whole cell lysate and biotinylated UTR RNA were halved.
Nano-LC FT-mass spectrometry (MS) analysis MS was performed using the system previously described (King et al., 2006) . The survey scans (m/z ¼ 350-2000) were acquired using FTICR-MS with a resolution of 100 000 at m/ z ¼ 421.75 with a target value of 500 000. The ten most intense ions from survey scans were isolated in the ion trap and analyzed after reaching a target value of 10 000. The MS/MS isolation width was 2.5 Da and the normalized collision energy was 35% using wide band activation. The electrospray ionization was accomplished with a spray voltage of 2.2 kV without sheath gas. The ion transfer tube temperature was 200 1C.
RNA interference
The following HP GenomeWide (Qiagen, Valencia, CA, USA) siRNA oligonucleotides were used: FBP1-2 (5 0 -CAGG AACGGGCTGGTGTTAAA-3 0 ), FBP1-3 (5 0 -ATGCTTTGT GATATAAATGTA-3 0 ) and NPM1-3 (5 0 -CAAGTTCATT AATTATGTGAA -3 0 ). As a control, siCONTROL RISC-free siRNA (Dharmacon, Lafayette, CO, USA, D-001220-01-05) was used. Tsc1
À/À MEFs (2 Â 10 6 ) were transfected with 0.2 nM of oligonucleotide using the Nucleofector system (Amaxa) according to the manufacturer's instructions. Cells were assayed 48 h after transfection.
FBP1 overexpression Tsc1
À/À p53 À/À MEFs (2 Â 10 6 ) were transfected with pGL3 Control (Promega; 2 mg) or Flag-FBP1 (Origene, Rockville, MD, USA; 2 mg) using the Nucleofector system (Amaxa) according to the manufacturer's instructions. Cells were assayed 24 h post-transfection.
Immunofluorescence Tsc1
À/À p53 À/À MEFs were transduced with pGL3 Control (Promega; 2 mg) or Flag-FBP1 (Origene; 2 mg) using the Nucleofector system (Amaxa). To induce formation of stress granules, cells were treated with 0.5 mM sodium arsenite (Sigma, S7400) for 1 h. Cells were fixed with 4% paraformaldehyde and were permeabilized with methanol. The following antibodies were used at the dilutions indicated: anti-Flag M2 (Sigma, F1804; 1:100) and anti-TIA-1 (Santa Cruz, sc1751; 1:100).
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